SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Taiho Pharmaceutical And Sanofi-Aventis (France) Conclude Licensing Agreement For Oral Pyrimidine Fluoride-Derived Anticancer Agent TS-1